Human epidermal growth factor receptor 2 (Her2) (alias receptor tyrosine-protein kinase erbB-2 (ERBB2) or cluster of differentiation 340 (CD340))-positive breast cancer patients have high serum levels of CCL5 associated with poor prognosis [134]. Here, CCL5 is linked to breast carcinoma.